Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluid vs. Catecholamine Restriction in DIEP Flap Reconstruction
NCT03118024Unknown
- Sponsor
- University of Regensburg
- Start
- Mar 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of norepinephrine in breast reconstruction, sponsored by University of Regensburg. Primary endpoint: Free flap survival rate at 5 days. Status: unknown.
02
Drugs
norepinephrine
03
Conditions
breast reconstruction
Beyond the preview
Go deeper on NCT03118024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03118024.